One of the most notorious gougers of the pharmaceutical industry is bankrupt, but 2019 is a record year for price hikes of pharmaceutical shkreli-grad / Boing Boing



[ad_1]

In September 2016, Novum Pharma made the headlines by raising the price of Aloquin, a low-cost acne cream from $ 240 / tube to $ 10,000 / tube, after acquiring the exclusive right to to make it.

Now, Novum is bankrupt, which it attributes to price increases that led to "a public review regarding [Novum’s] economic model and even higher order rejection rates ".

Although this is a reason to encourage, do not be too happy. As Beth Mole points out at Ars Technica: "Despite the public's attention to the price of medicines, more than three dozen pharmaceutical companies have started 2019 with dramatic price increases for hundreds of drugs."

Although bankruptcy may seem like a victory in the battle to lower drug prices, Craig Garthwaite, director of health care at the Kellogg School of Management at Northwestern University, did not have such an optimistic view. "I think we see companies that are sensitive to the announcement of these price changes. I do not think we are witnessing a radical change in behavior, "he told the Tribune.

The infamous pharmaceutical company declares bankruptcy after a price increase of 3 900% [Beth Mole/Ars Technica]

<! –

Cory Doctorow

I write books. My latest are: A graphic novel by YA titled In Real Life (with Jen Wang); a documentary book on the arts and the Internet titled Information Does not Want to Be Free: Laws for the Internet Age (with introductions by Neil Gaiman and Amanda Palmer) and a science fiction novel YA entitled Homeland (continuation of Little Brother). I speak everywhere and I tweet and tumble too.

->

[ad_2]
Source link